New tech in biotech

Can biotech deliver new antibiotics?

The evolution of support for the discovery and development of antibacterial (or antibiotic) agents from the larger pharmaceutical companies to the entrepreneur-like small biotechnology companies has been an experiment in the making for the past 15 years. The word 'experiment' is precisely chosen as the outcome is not certain. Many of the antibiotic biotech organizations that were most likely to...

Competiveness and Innovation in High-tech Companies: an Application to the Italian Biotech and Aerospace Industries

Innovation activities are a critical factor in national and regional development. The innovative behaviour of companies is one of the main sources of competitiveness, business survival, economic growth and employment in a territory. It is therefore important to identify and understand the factors that determine innovation behaviour among enterprises. In line with...

Tuning In to Technology Benefits of Biotech , Computational Tech , and Nanotech

Will biotech venture thrive in the new climate in Japan?

I recently kicked off a biotech venture company in Japan. This is something unusual to see here, as there are few university-based startup companies in this country. According to one statistic, the number of biotech venture companies in Japan is now around 60, very many fewer than in the US which has around 1,700. Only ten new companies started last year and most of them were backed by establis...

Special: Biotech in Russia

Traditions of Russian fundamental and applied life sciences go back to the last third of the nineteenth century, the reign of “Tzar-Liberator” Alexander II. Basic scientific schools in organic chemistry and life sciences appeared in St. Petersburg, Moscow, Kazan, Kiev, and Warshaw. Since then, Russian bioscience and biotechnology has experienced rises and falls together with the whole country.